{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:03:49Z","timestamp":1761224629107,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.drudis.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T12:49:19Z","timestamp":1536583759000},"page":"279-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Do urocortins have a role in treating cardiovascular disease?"],"prefix":"10.1016","volume":"24","author":[{"given":"Ekaterini","family":"Chatzaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikoleta","family":"Kefala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fani","family":"Lalidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula","family":"Baritaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2018.09.004_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/gcen.1999.7298","article-title":"Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates","volume":"115","author":"Lovejoy","year":"1999","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-328X(99)00076-5","article-title":"Ovine genomic urocortin: cloning, pharmacologic characterization, and distribution of central mRNA","volume":"68","author":"Cepoi","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.drudis.2018.09.004_bib0020","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1210\/endo.140.12.7223","article-title":"Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids","volume":"140","author":"Kageyama","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2018.09.004_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000187136","article-title":"Neuropeptide urocortin 1 and its receptors are expressed in the human liver","volume":"89","author":"Simopoulos","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.drudis.2018.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.bjp.0704587","article-title":"Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels","volume":"135","author":"Huang","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0035","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.121165198","article-title":"Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor","volume":"98","author":"Lewis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.09.004_bib0040","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.051626398","article-title":"Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors","volume":"98","author":"Reyes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.09.004_bib0045","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/87936","article-title":"Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor","volume":"7","author":"Hsu","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2018.09.004_bib0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jcem.87.1.8160","article-title":"Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart","volume":"87","author":"Kimura","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2018.09.004_bib0055","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2003-031663","article-title":"Expression of urocortin III\/stresscopin in human heart and kidney","volume":"89","author":"Takahashi","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2018.09.004_bib0060","doi-asserted-by":"crossref","first-page":"H3031","DOI":"10.1152\/ajpheart.2000.279.6.H3031","article-title":"Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart","volume":"279","author":"Nishikimi","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0065","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1073\/pnas.92.3.836","article-title":"Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain","volume":"92","author":"Lovenberg","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.09.004_bib0070","first-page":"1077","article-title":"Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor","volume":"12","author":"Kostich","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.drudis.2009.04.002","article-title":"The corticotropin-releasing factor system in inflammatory bowel disease: prospects for new therapeutic approaches","volume":"14","author":"Paschos","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2018.09.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2006.09.002","article-title":"Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs","volume":"28","author":"Fekete","year":"2007","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0085","doi-asserted-by":"crossref","first-page":"G511","DOI":"10.1152\/ajpgi.00289.2005","article-title":"Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats","volume":"290","author":"Czimmer","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0090","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1258\/ebm.2010.009347","article-title":"Corticotropin-releasing factor signaling and visceral response to stress","volume":"235","author":"Stengel","year":"2010","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.drudis.2018.09.004_bib0095","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1210\/en.2006-0967","article-title":"Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner","volume":"148","author":"Dermitzaki","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2018.09.004_bib0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/med.21268","article-title":"The corticotropin releasing factor system in the kidney: perspectives for novel therapeutic intervention in nephrology","volume":"33","author":"Devetzis","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.drudis.2018.09.004_bib0105","doi-asserted-by":"crossref","first-page":"R1244","DOI":"10.1152\/ajpregu.00445.2015","article-title":"Sex- and corticotropin-releasing factor receptor 2-dependent actions of urocortin 1 during inflammation","volume":"310","author":"Hasdemir","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0110","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1172\/JCI112204","article-title":"Immunoreactive corticotropin-releasing factor in human plasma","volume":"76","author":"Suda","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2018.09.004_bib0115","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.peptides.2006.07.005","article-title":"CRF receptors in the rodent and human cardiovascular systems: species differences","volume":"27","author":"Waser","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2018.09.004_bib0120","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.peptides.2004.04.018","article-title":"Urocortins as cardiovascular peptides","volume":"25","author":"Takahashi","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2018.09.004_bib0125","doi-asserted-by":"crossref","first-page":"395284","DOI":"10.1155\/2012\/395284","article-title":"Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system","volume":"2012","author":"Takahashi","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0130","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1210\/endo.141.7.7572","article-title":"Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines","volume":"141","author":"Kageyama","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2018.09.004_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1025551305777","article-title":"Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases","volume":"252","author":"Ikeda","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.drudis.2018.09.004_bib0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCHEARTFAILURE.108.840207","article-title":"Plasma urocortin 1 in human heart failure","volume":"2","author":"Wright","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.drudis.2018.09.004_bib0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03401403","article-title":"Corticotropin-releasing factor (CRF) system localization in human fetal heart","volume":"15","author":"Chouridou","year":"2016","journal-title":"Hormones"},{"key":"10.1016\/j.drudis.2018.09.004_bib0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0196-9781(01)00396-5","article-title":"Cardiovascular actions of CRH and urocortin: an update","volume":"22","author":"Parkes","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2018.09.004_bib0155","first-page":"H2115","article-title":"Cardiac inotropic actions of urocortin in conscious sheep","volume":"272","author":"Parkes","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000090132","article-title":"Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin","volume":"43","author":"Honjo","year":"2006","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.drudis.2018.09.004_bib0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2008.01.157","article-title":"Urocortin: a beneficial or detrimental agent to endothelium?","volume":"371","author":"Yang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2018.09.004_bib0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/bbrc.1998.9297","article-title":"Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes","volume":"250","author":"Ikeda","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2018.09.004_bib0175","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbrc.2005.01.001","article-title":"Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway","volume":"328","author":"Chanalaris","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2018.09.004_bib0180","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1074\/jbc.275.12.8508","article-title":"Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway","volume":"275","author":"Brar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.09.004_bib0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/378287a0","article-title":"Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor","volume":"378","author":"Vaughan","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2018.09.004_bib0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(96)00141-0","article-title":"Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats","volume":"303","author":"Turnbull","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1677\/joe.0.1690177","article-title":"Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart","volume":"169","author":"Terui","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110866","article-title":"Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo","volume":"9","author":"Hasegawa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.09.004_bib0205","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.cardiores.2004.11.018","article-title":"Urocortin-induced relaxation in the human internal mammary artery","volume":"65","author":"Chen","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.drudis.2018.09.004_bib0210","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.bjp.0705985","article-title":"CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators","volume":"143","author":"Wiley","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1681.2010.05466.x","article-title":"Urocortin-2 induces vasorelaxation of coronary arteries isolated from patients with heart failure","volume":"38","author":"Smani","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0220","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jtcvs.2009.03.041","article-title":"Warm-blood cardioplegic arrest induces selective mitochondrial translocation of protein kinase Cepsilon followed by interaction with 6.1 inwardly rectifying potassium channel subunit in viable myocytes overexpressing urocortin","volume":"138","author":"Chen-Scarabelli","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.drudis.2018.09.004_bib0225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/CS20030311","article-title":"Plasma urocortin in human systolic heart failure","volume":"106","author":"Ng","year":"2004","journal-title":"Clin. Sci."},{"key":"10.1016\/j.drudis.2018.09.004_bib0230","first-page":"115","article-title":"Relationship of urocortin-2 with systolic and diastolic functions and coronary artery disease: an observational study","volume":"12","author":"Topal","year":"2012","journal-title":"Anadolu. Kardiyol. Derg."},{"key":"10.1016\/j.drudis.2018.09.004_bib0235","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/jc.2003-031231","article-title":"Urocortin-1 infusion in normal humans","volume":"89","author":"Davis","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2018.09.004_bib0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2006.09.035","article-title":"Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses","volume":"49","author":"Davis","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2018.09.004_bib0245","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/eurheartj\/ehm340","article-title":"Urocortin 2 infusion in human heart failure","volume":"28","author":"Davis","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.drudis.2018.09.004_bib0250","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jchf.2013.07.003","article-title":"Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy)","volume":"1","author":"Chan","year":"2013","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.drudis.2018.09.004_bib0255","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004267","article-title":"Vascular effects of urocortins 2 and 3 in healthy volunteers","volume":"2","author":"Venkatasubramanian","year":"2013","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.drudis.2018.09.004_bib0260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/eurjhf\/hft023","article-title":"Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction","volume":"15","author":"Gheorghiade","year":"2013","journal-title":"Eur. J. Heart Fail."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618302332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618302332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:37:30Z","timestamp":1761223050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644618302332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1359644618302332"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2018.09.004","relation":{},"ISSN":["1359-6446"],"issn-type":[{"type":"print","value":"1359-6446"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do urocortins have a role in treating cardiovascular disease?","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}